The daily business briefing: October 16, 2023
Rite Aid files for bankruptcy protection, Taylor Swift's concert movie breaks records, and more
1. Rite Aid files for bankruptcy
Rite Aid said Sunday it had filed for bankruptcy after failing to come up with the money to settle hundreds of federal, state and private lawsuits accusing the pharmacy chain of filling illegal painkiller prescriptions. Rite Aid, hobbled by declining sales, said it had obtained $3.45 billion in financing to keep operating as it restructures its debt. The company appointed a new chief executive, Jeffrey Stein, to lead the restructuring, which will include the closing of more of the chain's 2,100 stores. Rite Aid is one of several pharmacy chains facing lawsuits over their alleged roles in fueling the opioid crisis. The Justice Department in March accused the company of filling painkiller prescriptions despite obvious "red flags indicating misuse." The Wall Street Journal, The New York Times
2. Taylor Swift's concert movie breaks records
Taylor Swift's Eras Tour concert film led the weekend box office, bringing in an estimated $95 million to $97 million in its theatrical debut. It instantly became the biggest concert film ever, surpassing Justin Bieber's 2011 "Never Say Never," which grossed $73 million domestically over its entire run, Rolling Stone reported. The film on Swift's tour, which is likely to be the biggest-grossing concert tour ever, also broke the record for the widest-released concert film in history, appearing on more than 3,850 domestic screens in its opening weekend. Once the final numbers are in, Swift's Eras Tour concert movie even could break the record for the biggest October opening, now held by 2019's "The Joker" ($96.2 million). Rolling Stone, CNBC
3. Dow, S&P edge higher ahead of wave of earnings
U.S. stock futures rose early Monday ahead of a big week of corporate earnings reports. Futures tied to the Dow Jones Industrial Average and the S&P 500 were up 0.4% and 0.3%, respectively, at 7:30 a.m. ET. Nasdaq futures were flat. Eleven percent of S&P 500 companies are scheduled to report quarterly results this week. Johnson & Johnson, Bank of America, Netflix and Tesla get things started with their reports before trading begins. JPMorgan Chase, Wells Fargo and UnitedHealth got earnings season off to a good start last week, sending their stocks up on Friday. Global markets showed caution due to concerns the Israel-Hamas conflict could spread. CNBC
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
4. EV sales growth slows
U.S. sales of electric vehicles continued to rise in September, bringing this year's growth to 51%, The Wall Street Journal reported Sunday. Automakers had waiting lists for EVs last year, but the growth rate has slowed, leaving dealers with ballooning inventories of some models as demand proves weaker than anticipated. Some leading automakers, including Ford and Toyota, are shifting resources toward hybrids. "The curve isn't accelerating as quickly as I think a lot of people expected," John Lawler, Ford Motor's chief financial officer, said last month. In Germany, EV sales fell sharply last month after the government ended incentives for business buyers. The Wall Street Journal, Inside EVs
5. Pfizer cuts forecast for Covid vaccine, therapy sales
Shares of Pfizer and its German partner, BioNTech, dropped Monday after the U.S. drugmaker last week cut its forecast for Covid vaccine and therapy sales. Pfizer said Friday it was slashing its full-year forecast for sales of the vaccine it developed with BioNTech by $2 billion, and for its Covid antiviral treatment Paxlovid by $7 billion. The reductions were bigger than expected, Wells Fargo analyst Mohit Bansal told Reuters. Pfizer's shares fell 3.5% in pre-market trading. BioNTech shares were down 6.7% in Frankfurt. Rival Covid vaccine maker Moderna's shares were down 3.8%. Reuters
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Harold Maass is a contributing editor at The Week. He has been writing for The Week since the 2001 debut of the U.S. print edition and served as editor of TheWeek.com when it launched in 2008. Harold started his career as a newspaper reporter in South Florida and Haiti. He has previously worked for a variety of news outlets, including The Miami Herald, ABC News and Fox News, and for several years wrote a daily roundup of financial news for The Week and Yahoo Finance.
-
Today's political cartoons - May 11, 2024
Cartoons Saturday's cartoons - bathroom blues, family feud, and more
By The Week US Published
-
5 blustery cartoons about the Stormy Daniels testimony
Cartoons Artists take on gag orders, lurid details, and more
By The Week US Published
-
The Idea of You review: 'impossible escapism' starring Anne Hathaway
The Week Recommends Steamy romcom about a 40-year-old who falls for a boy band singer
By The Week UK Published
-
Downtown St. Louis is in a real estate 'doom loop'
Under the Radar The city is rife with abandoned buildings and vacant lots, with its real estate market in dire straits
By Justin Klawans, The Week US Published
-
How will the FTC's ban on noncompete agreements affect the workforce?
The explainer Short answer: Competition will only get fiercer
By Devika Rao, The Week US Published
-
Why is Tesla stumbling?
In the Spotlight More competition, confusion about the future and a giant pay package for Elon Musk
By Joel Mathis, The Week US Published
-
The wine industry is getting pressed as young people drink less
Under the Radar The once-dominating drink is not aging well
By Anya Jaremko-Greenwold, The Week US Published
-
The largest insurance company payouts
In The Spotlight Fights over insurance have been in the spotlight following the collapse of the Francis Scott Key Bridge in Baltimore
By Justin Klawans, The Week US Published
-
Disney board fends off Peltz infiltration bid
Speed Read Disney CEO Bob Iger has defeated activist investor Nelson Peltz in a contentious proxy battle
By Rafi Schwartz, The Week US Published
-
Visa and Mastercard agree to lower swipe fees
Speed Read The companies will cap the fees they charge businesses when customers use their credit cards
By Peter Weber, The Week US Published
-
Reddit IPO values social media site at $6.4 billion
Speed Read The company makes its public debut on the New York Stock Exchange
By Peter Weber, The Week US Published